In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Inverness gains OTC diagnostics via $25mm First Check buy

Executive Summary

Diagnostics company Inverness Medical Innovations has taken on a new set of consumer tests for drugs of abuse after buying First Check Diagnostics for $25mm in cash. IMI will also pay an earn-out equal to the increase of the acquired products' sales in FY2007 through the first three quarters of 2008 over sales during FY2006 plus the first three quarters of 2007.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Urine-based Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies